Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3087182rdf:typepubmed:Citationlld:pubmed
pubmed-article:3087182lifeskim:mentionsumls-concept:C0035372lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C0005496lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C1751431lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C0032744lld:lifeskim
pubmed-article:3087182lifeskim:mentionsumls-concept:C0233929lld:lifeskim
pubmed-article:3087182pubmed:dateCreated1986-6-27lld:pubmed
pubmed-article:3087182pubmed:abstractTextWe report on the first positron emission tomographic study of dopamine receptor binding in Rett syndrome. The patient is a 25 year old Austrian woman diagnosed at age 2 and followed since then by Rett. A computed axial tomogram (CT scan) showed cortical atrophy, and enlarged ventricles but normal structure of the caudate/putamen. Following the CT scan 20 mCi of 11 C N-methyl spiperone, a butyrophenone with a high affinity for dopamine D2 receptors was administered intravenously. The patient was found to have dopamine D2 receptor binding activity in the low normal range. The caudate/cerebellar activity ratio was below the mean regression line (p = 0.10) that relates the CA/CB ratio as a function of age. Levels of cerebrospinal fluid neurotransmitter metabolites were normal.lld:pubmed
pubmed-article:3087182pubmed:languageenglld:pubmed
pubmed-article:3087182pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087182pubmed:citationSubsetIMlld:pubmed
pubmed-article:3087182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087182pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087182pubmed:statusMEDLINElld:pubmed
pubmed-article:3087182pubmed:issn1040-3787lld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:MoserH WHWlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:NaiduSSlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:WagnerH NHNJrlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:BatshawM LMLlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:RettAAlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:HarrisJ CJClld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:LinksJ MJMlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:DannalsR FRFlld:pubmed
pubmed-article:3087182pubmed:authorpubmed-author:WongD FDFlld:pubmed
pubmed-article:3087182pubmed:issnTypePrintlld:pubmed
pubmed-article:3087182pubmed:volume1lld:pubmed
pubmed-article:3087182pubmed:ownerNLMlld:pubmed
pubmed-article:3087182pubmed:authorsCompleteYlld:pubmed
pubmed-article:3087182pubmed:pagination201-10lld:pubmed
pubmed-article:3087182pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:meshHeadingpubmed-meshheading:3087182-...lld:pubmed
pubmed-article:3087182pubmed:year1986lld:pubmed
pubmed-article:3087182pubmed:articleTitlePositron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome.lld:pubmed
pubmed-article:3087182pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3087182pubmed:publicationTypeCase Reportslld:pubmed